The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

May 1, 2014 • By Atul Deodhar, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Clinical Pearls: What We Know About Nonradiographic Axial Spondyloarthritis
  • New Guideline: NSAIDs Effective in Treating Ankylosing Spondylitis & Nonradiographic Axial Spondyloarthritis
  • NSAIDs Effective for Early Axial Spondyloarthritis
Explore This Issue
May 2014
Diagnosing Axial Spondyloarthritis
Someone with back pain starting before the age of 45 and lasting longer than three months has a 5% chance of having axSpA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It’s not often that rheuma­tologists name and define a recognized disease entity, but lack a framework to diagnose the disease.

In the recent past, it was conceptually understood that ankylosing spondylitis (AS) patients do not develop radiographic sacroili­itis soon after developing the symptoms of the disease, but we had limited ways to objectively assess such patients. In addition, there was no accepted nomenclature to label their condition. The past few years have witnessed remarkable progress in our understanding of the natural history, epidemiology and genetics of our patients who have axial skeletal inflammation—some of whom may develop structural damage at the sacroiliac joints at a later stage. This process has led to defining axial spondyloarthritis as an umbrella term, which includes AS plus patients with axial inflammation who do not have X-ray changes suggestive of structural damage that currently defines AS.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

This article touches upon the recent developments in this field, tries to clarify some misconceptions regarding the use of the new terminology and discusses new questions raised regarding the appropriate application of the axSpA classification criteria.

Spectrum of Disease

Axial spondyloarthritis is not just the “early stage of AS”: It is the entire spectrum of disease, which includes AS plus those with axial inflammation who may or may not develop the structural damage that defines AS at a later stage.

The most common presenting symptom of immune-mediated inflammatory involvement of the axial skeleton is chronic low back pain, most likely inflammatory back pain (see Table 1).2 Clinical features, such as asymmetric oligoarthritis, psoriasis, uveitis or enthesitis, may be present at this early stage, suggesting the presence of spondyloarthritis. Radiographic sacroiliitis would be absent at the early stage, and thus, such a person cannot be classified as AS using the modified New York (mNY) Criteria (see Table 2).3 Observational studies have shown that about 12% of such patients would progress to develop AS over two years and about 70% over the long term.4 High CRP, extensive MRI changes of sacroiliitis, male sex and smoking are risk factors for such a progression.5 The Assessment of Spondyloarthritis International Society (ASAS) has proposed a new term, axial spondyloarthritis (axSpA), to describe the entire spectrum of this disease in which the condition of patients who fulfill the modified New York (mNY) criteria is called ankylosing spondylitis, and that of patients not fulfilling the X-ray criteria is called nonradiographic axial spondyloarthritis (nr-axSpA)6 (see Table 3, Figure 1).

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 7 8 | Single Page

Filed Under: Conditions, Spondyloarthritis Tagged With: Ankylosing Spondylitis, antiinflammatory, axial skeletal inflammation, axial spondyloarthritis (SpA), Drugs, epidemiology, imaging, Pain, patient care, radiograph, Research, rheumatologist, rituximab, terminology, TofacitinibIssue: May 2014

You Might Also Like:
  • Clinical Pearls: What We Know About Nonradiographic Axial Spondyloarthritis
  • New Guideline: NSAIDs Effective in Treating Ankylosing Spondylitis & Nonradiographic Axial Spondyloarthritis
  • NSAIDs Effective for Early Axial Spondyloarthritis
  • From Chronic Low Back Pain to Axial Spondyloarthritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)